Skip to main content
. 2022 Mar 19;10(3):713. doi: 10.3390/biomedicines10030713

Figure 1.

Figure 1

The therapeutic insights of natural compounds targeting CAFs (cancer-associated fibroblasts). CAFs in the TME (tumor microenvironment) are the critical contributor of tumorigenesis, cancer progression, and metastasis. The therapeutic strategies targeting CAFs are still flourishing. Several natural products have been discovered to have the potential to inhibit CAFs activation, proliferation, and tumor-promoting functions.